Pfizer admits paying $35 million to doctors over last 6 months

NewsGuard 100/100 Score

Pfizer among other large pharmaceutical companies recently disclosed payments to doctors and other medical professionals for consulting and speaking on its behalf and also some sponsorship of clinical trials. On Wednesday in an announcement the company spokesperson revealed that they had paid a whopping $20 million to 4,500 doctors and other medical professionals in the last six months of 2009. Pfizer also accepted that they paid $15.3 million to 250 academic medical centers and other research groups for clinical trials in the same period. This disclosure is only about payments made within the US.

A spokeswoman for Pfizer, Kristen E. Neese, said that these disclosures were required by an integrity agreement that the company signed in August to settle a federal investigation into the illegal promotion of drugs for off-label uses. Dr. Freda C. Lewis Hall, Pfizer’s chief medical officer said that this disclosure and web portal was a part of “a march to disclosure” that the company started in 2002. Ms. Neese said that these disclosures improve transparency of conduct of the pharmaceutical companies.

The disclosures, which are posted on its website,, involve those who received payments, meals or non-monetary educational items worth $25 or more, according to Pfizer.

Three other ‘pharma’ giants Eli Lilly, Merck and Glaxosmithkline have already made such disclosures but have not revealed their role in clinical trials. From 20102 the pharmaceutical and medical services companies will have to make disclosures of payments to doctors of more than $10, with the first report available in 2013. The Physician Payment Sunshine Act was passed as part of health care reform. Some states also have disclosure laws.

This disclosure according to M Neese also includes payments made to academic centers, nurse practitioners and physician’s assistants. This is something that the Sunshine Law does not mandate. Further Pfizer claimed no imposing delay of up to four years on financial support for clinical trials.

Dr. Marcia Angell, former editor of The New England Journal of Medicine said, “If they’re doing that — it would amaze me if they did, but if they are — that’s great.” But she also said that these amounts seem too low. “I can’t help but think something has escaped,” she said.

This disclosure has raised issues of conflicts of interest in medicine.

“I think it’s a good thing to do, but I put absolutely no trust in what drug companies voluntarily disclose to the public when those things are unaudited,” said Eric G. Campbell, lead author of a 2007 study of physician-industry relationships published in The New England Journal of Medicine.

It is illegal to promote drugs for uses that are not cleared by the US Food and Drug Administration. Pfizer last September was accused of this offence and fined. In fact in 2004 Pfizer had pleaded guilty for improper sales tactics and its practices. This disclosure is thus taken with a pinch of salt by many.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Pfizer admits paying $35 million to doctors over last 6 months. News-Medical. Retrieved on May 18, 2024 from

  • MLA

    Mandal, Ananya. "Pfizer admits paying $35 million to doctors over last 6 months". News-Medical. 18 May 2024. <>.

  • Chicago

    Mandal, Ananya. "Pfizer admits paying $35 million to doctors over last 6 months". News-Medical. (accessed May 18, 2024).

  • Harvard

    Mandal, Ananya. 2018. Pfizer admits paying $35 million to doctors over last 6 months. News-Medical, viewed 18 May 2024,


  1. Simon Carbajal Simon Carbajal Belgium says:

    Can we read somewhere else those amounts? or we just need to trust you?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research explores the health benefits of resistant starch in plant-based diets